]>
IRCT20211207053313N1 IRCT 2021-12-12 Ahvaz University of Medical Sciences The effect of Matricaria Chamonail on postpartum depression The effect of Matricaria Chamonail on postpartum depression 2022-01-10 anticipated 144 Complete https://irct.ir/trial/60557 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The subjects will be divided into two groups of 72 people in the chamomile extract group and the placebo group by random block allocation method and using 6 blocks. In order to prevent the occurrence of selection bias, the Allocation Concealment method will be used by placing the sample code in closed and two-layer envelopes and keeping these envelopes with the secretary of health centers, Blinding description: Blinding will be done in the form of double-sided blinds; In order to reduce the possibility of information bias, the capsules will be coded by the pharmaceutical company. Patients and individuals who provide drugs or evaluate the results of the treatment will be unaware of the type of treatment assigned to each person. 3 Postpartum depression. Intervention 1: Intervention group: People will be advised to take two capsules of 500 mg of chamomile extract daily. Patients will be contacted twice a week. at the first visit, capsules will be given to them to continue treatment until week 8. At the end, Beck questionnaire will be completed by them. 500mg chamomile capsules standardized with 1.2% flavonoid of Gol Darou company are prepared. Participants received 1,000 mg daily (twice daily) for 8 weeks. Intervention 2: Control group: Placebo capsules filled with saccharin powder are provided by Gol Daroo Company. The capsules are similar in shape, size and packaging to the capsules containing chamomile extract. The capsules will be named by the pharmaceutical company. Participants will receive placebo twice a day for 8 weeks. Patients will be contacted twice a week. t. at the first visit, capsules will be given to them to continue treatment until week 8. At the end, Beck questionnaire will be completed by them. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is I will make a decision after the intervention
public Maryam Eradi
Esfand St., Golestan, Ahvaz, Iran
Ahvaz Iran (Islamic Republic of) 6461158753 +98 61 4223 1706 eradi.m@ajums.ac.ir Ahvaz University of Medical Sciences scientific Maryam Eradi
Esfand St., Golestan, Ahvaz, Iran
Ahvaz Iran (Islamic Republic of) 6461158753 +98 61 4223 1706 eradi.m@ajums.ac.ir Ahvaz University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Iran (Islamic Republic of) Iran (Islamic Republic of) Having a cell phone Women with mild to moderate depression who are in the second week after delivery until 6 months later. Term, single and alive baby delivery Being literate Age 18 to 45 years Women with mild to moderate depression who are in the second week after delivery until 6 months later. 18 years 45 years Female Treatment - Drugs Placebo Intervention group: People will be advised to take two capsules of 500 mg of chamomile extract daily. Patients will be contacted twice a week. at the first visit, capsules will be given to them to continue treatment until week 8. At the end, Beck questionnaire will be completed by them. 500mg chamomile capsules standardized with 1.2% flavonoid of Gol Darou company are prepared. Participants received 1,000 mg daily (twice daily) for 8 weeks Control group: Placebo capsules filled with saccharin powder are provided by Gol Daroo Company. The capsules are similar in shape, size and packaging to the capsules containing chamomile extract. The capsules will be named by the pharmaceutical company. Participants will receive placebo twice a day for 8 weeks. Patients will be contacted twice a week. t. at the first visit, capsules will be given to them to continue treatment until week 8. At the end, Beck questionnaire will be completed by them. The average score of depression. Timepoint: Before the intervention nd 8 weeks after the start of treatment. Method of measurement: Beck Depression questionnaire. The severity of depression. Timepoint: Before the intervention and 8 weeks after the start of treatment. Method of measurement: Beck depression questionnaire. Ahvaz University of Medical Sciences Approved 2021-11-23 Ethics committee of Ahvaz University of Medical Sciences No. 491, Imamat St., Jomhuri Eslami Blvd., Dezful Town Dezful Khouzestan Iran (Islamic Republic of)